Skip to main content
SpringerLink
Log in

Prevalence and Clinical Characteristics of Brugada Syndrome

  • Chapter
  • First Online:
J Wave Syndromes

  • 685 Accesses

Abstract

Over 20 years ago the sentinel report was published on a disease entity now known as Brugada syndrome. Brugada syndrome is characterized by a coved-type ST segment in the right precordial leads and shows a propensity for ventricular and supraventricular arrhythmias. In this chapter its prevalence and clinical characteristics are summarized. This also includes an overview on the latest consensus report and an overview on the treatment of both ventricular and supraventricular arrhythmias in Brugada syndrome patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20:1391–6.

    Article  CAS  PubMed  Google Scholar 

  2. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang C-E, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes expert consensus statement on inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932–63.

    Google Scholar 

  3. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J. 2002;23:1648–54.

    Article  CAS  PubMed  Google Scholar 

  4. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, Le Marec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2005;2:429–40.

    Article  PubMed  Google Scholar 

  5. Osher HL, Wollf L. Electrocardiographic pattern simulating acute myocardial injury. Am J Med Sci. 1953;226:541–5.

    Article  CAS  PubMed  Google Scholar 

  6. Edeiken J. Elevation of the RS-T segment, apparent or real, in the right precordial leads as a probable normal variant. Am Heart J. 1954;48:331–9.

    Article  CAS  PubMed  Google Scholar 

  7. Nava A, Canciani B, Schiavinato ML, Martini B, Buja G. La repolarisation precoce dans les precordiales droites: trouble de la conduction intraventriculaire droite? Correlations de l’electrocardiographie – vectorcardiographie avec l’electrophysiologie. Mises J Cardiol. 1988;17:157–9.

    Google Scholar 

  8. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, Dalla VS. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J. 1989;118:1203–9.

    Article  CAS  PubMed  Google Scholar 

  9. Richter S, Sarkozy A, Veltmann C, Chierchia GB, Boussy T, Wolpert C, Schimpf R, Brugada J, Brugada R, Borggrefe M, Brugada P. Variability of the diagnostic ECG pattern in an ICD patient population with Brugada syndrome. J Cardiovasc Electrophysiol. 2009;20:69–75.

    Article  PubMed  Google Scholar 

  10. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, Spehl S, Borggrefe M, Wolpert C. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J. 2006;27:2544–54.

    Article  PubMed  Google Scholar 

  11. Take Y, Morita H, Wu J, Nagase S, Morita S, Toh N, Nishii N, Nakamura K, Kusano KF, Ohe T, Ito H, Zipes DP. Spontaneous ECG alterations predict ventricular fibrillation in Brugada syndrome. Heart Rhythm. 2011;8:1014–21.

    Article  PubMed  Google Scholar 

  12. Ikeda T, Takami M, Sugi K, Mizusawa Y, Sakurada H, Yoshino H. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol. 2005;10:396–403.

    Article  PubMed  Google Scholar 

  13. Letsas KP, Sacher F, Probst V, Weber R, Knecht S, Kalusche D, Haissaguerre M, Arentz T. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome. Heart Rhythm. 2008;5:1685–9.

    Article  PubMed  Google Scholar 

  14. Veltmann C, Papavassiliu T, Konrad T, Doesch C, Kuschyk J, Streitner F, Haghi D, Michaely HJ, Schoenberg SO, Borggrefe M, Wolpert C, Schimpf R. Insights into the location of type I ECG in patients with Brugada syndrome: correlation of ECG and cardiovascular magnetic resonance imaging. Heart Rhythm. 2012;9:414–21.

    Article  CAS  PubMed  Google Scholar 

  15. Shimeno K, Takagi M, Maeda K, Tatsumi H, Doi A, Yoshiyama M. Usefulness of multichannel holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG: comparison with repeated 12-lead ECGs. J Cardiovasc Electrophysiol. 2009;20:1026–31.

    Article  PubMed  Google Scholar 

  16. Ikeda T, Abe A, Yusu S, Nakamura K, Ishiguro H, Mera H, Yotsukura M, Yoshino H. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol. 2006;17:602–7.

    Article  PubMed  Google Scholar 

  17. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27:1061–70.

    Article  CAS  PubMed  Google Scholar 

  18. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation. 2000;101:510–5.

    Article  CAS  PubMed  Google Scholar 

  19. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD, Guerchicoff A, Matsuo K, Burashnikov E, Dumaine R, Towbin JA, Nesterenko V, Brugada P, Antzelevitch C, Brugada R. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation. 2004;110:3023–7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol. 2006;17:857–64.

    Article  PubMed  Google Scholar 

  21. Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S. Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Electrophysiol. 2003;26:338–41.

    Article  PubMed  Google Scholar 

  22. Veltmann C, Wolpert C, Sacher F, Mabo P, Schimpf R, Streitner F, Brade J, Kyndt F, Kuschyk J, Le Marec H, Borggrefe M, Probst V. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace. 2009;11:1345–52.

    Article  PubMed  Google Scholar 

  23. Rolf S, Bruns HJ, Wichter T, Kirchhof P, Ribbing M, Wasmer K, Paul M, Breithardt G, Haverkamp W, Eckardt L. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J. 2003;24:1104–12.

    Article  CAS  PubMed  Google Scholar 

  24. Conte G, Sieira J, Sarkozy A, de Asmundis C, Di Giovanni G, Chierchia G-B, Ciconte G, Levinstein M, Casado-Arroyo R, Baltogiannis G, Saenen J, Saitoh Y, Gudrun Pappaert R, Brugada P. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features and prognosis. Heart Rhythm. 2013;10:1869–74.

    Article  PubMed  Google Scholar 

  25. Conte G, Dewals W, Sieira J, de Asmundis C, Ciconte G, Chierchia G-B, Di Giovanni G, Baltogiannis G, Saitoh Y, Levinstein M, La Meir M, Wellens F, Pappaert G, Brugada P. Drug-induced Brugada syndrome in children: clinical features, device-based management, and long-term follow-up. J Am Coll Cardiol. 2014;63:2272–9.

    Article  PubMed  Google Scholar 

  26. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, Streitner F, Kuschyk J, Schimpf R, Haase KK, Borggrefe M. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm. 2005;2:254–60.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Conte G, de Asmundis C, Ciconte G, Julià J, Sieira J, Chierchia G-B, Brugada P. Follow-up from childhood to adulthood of individuals with family history of Brugada syndrome and normal electrocardiograms. JAMA. 2014;312:2039–41.

    Article  PubMed  Google Scholar 

  28. Govindan M, Batchvarov VN, Raju H, Shanmugam N, Bizrah M, Bastiaenen R, Kiotsekoglou A, Camm J, Behr ER. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome. Heart. 2010;96:1904–8.

    Article  PubMed  Google Scholar 

  29. Amin AS, Meregalli PG, Bardai A, Wilde AA, Tan HL. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med. 2008;149:216–8.

    Article  PubMed  Google Scholar 

  30. Baranchuk A, Nguyen T, Ryu MH, Femenía F, Zareba W, Wilde AAM, Shimizu W, Brugada P, Pérez-Riera AR. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol. 2012;17:299–314.

    Article  PubMed  Google Scholar 

  31. Matsuo K, Akahoshi M, Nakashima E, Suyama A, Seto S, Hayano M, Yano K. The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades. J Am Coll Cardiol. 2001;38:765–70.

    Article  CAS  PubMed  Google Scholar 

  32. Miyasaka Y, Tsuji H, Yamada K, Tokunaga S, Saito D, Imuro Y, Matsumoto N, Iwasaka T. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol. 2001;38:771–4.

    Article  CAS  PubMed  Google Scholar 

  33. Furuhashi M, Uno K, Tsuchihashi K, Nagahara D, Hyakukoku M, Ohtomo T, Satoh S, Nishimiya T, Shimamoto K. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart. 2001;86:161–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Sakabe M, Fujiki A, Tani M, Nishida K, Mizumaki K, Inoue H. Proportion and prognosis of healthy people with coved or saddle-back type ST segment elevation in the right precordial leads during 10 years follow-up. Eur Heart J. 2003;24:1488–93.

    Article  PubMed  Google Scholar 

  35. Shin SC, Ryu HM, Lee JH, Chang BJ, Shin JK, Kim HS, Heo JH, Yang DH, Park HS, Cho Y, Chae SC, Jun JE, Park WH. Prevalence of the Brugada-type ECG recorded from higher intercostal spaces in healthy Korean males. Circ J. 2005;69:1064–7.

    Article  PubMed  Google Scholar 

  36. Bozkurt A, Yas D, Seydaoglu G, Acarturk E. Frequency of Brugada-type ECG pattern (Brugada sign) in Southern Turkey. Int Heart J. 2006;47:541–7.

    Article  PubMed  Google Scholar 

  37. Babaee Bigi MA, Aslani A, Shahrzad S. Prevalence of Brugada sign in patients presenting with palpitation in southern Iran. Europace. 2007;9:252–5.

    Article  Google Scholar 

  38. Gervacio-Domingo G, Isidro J, Tirona J, Gabriel E, David G, Amarillo ML, Morales D, Dans A. The Brugada type 1 electrocardiographic pattern is common among Filipinos. J Clin Epidemiol. 2008;61:1067–72.

    Article  PubMed  Google Scholar 

  39. Tsuji H, Sato T, Morisaki K, Iwasaka T. Prognosis of subjects with Brugada-type electrocardiogram in a population of middle-aged Japanese diagnosed during a health examination. Am J Cardiol. 2008;102:584–7.

    Article  PubMed  Google Scholar 

  40. Wajed A, Aslam Z, Abbas SF, Irfan M, Bangash K, Rehman S, Amin F. Frequency of Brugada-type ECG pattern (Brugada sign) in an apparently healthy young population. J Ayub Med Coll Abbottabad. 2008;20:121–4.

    PubMed  Google Scholar 

  41. Uhm JS, Hwang IU, Oh YS, Choi MS, Jang SW, Shin WS, Kim JH, Lee MY, Rho TH, Kim YH, Sung JH, Lee YS, Cho JG, Oh DJ, Kim DK, Namgung J, Park KM, Kim YH, Kim YN, Lim HE, Cha TJ, On YK, Shin DG, Pak HN, Kim NH. Prevalence of electrocardiographic findings suggestive of sudden cardiac death risk in 10,867 apparently healthy young Korean men. Pacing Clin Electrophysiol. 2011;34:717–23.

    Article  PubMed  Google Scholar 

  42. Juang JM, Phan WL, Chen PC, Lai LP, Tsai MH, Lin JW, Cheng PH, Chiu WY, Cheng BW, Hwang JJ, Tseng CD, Hsu KL, Tseng YZ, Lin JL, Chiang FT. Brugada-type electrocardiogram in the Taiwanese population-is it a risk factor for sudden death? J Formos Med Assoc. 2011;110:230–8.

    Article  PubMed  Google Scholar 

  43. Hermida JS, Lemoine JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol. 2000;86:91–4.

    Article  CAS  PubMed  Google Scholar 

  44. Junttila MJ, Raatikainen MJ, Karjalainen J, Kauma H, Kesaniemi YA, Huikuri HV. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J. 2004;25:874–8.

    Article  CAS  PubMed  Google Scholar 

  45. Blangy H, Sadoul N, Coutelour JM, Rebmann JP, Joseph M, Scherrer C, de Chillou C, Magnin-Poull I, Aliot E. Prevalence of Brugada syndrome among 35,309 inhabitants of Lorraine screened at a preventive medicine centre. Arch Mal Coeur Vaiss. 2005;98:175–80.

    CAS  PubMed  Google Scholar 

  46. Letsas KP, Gavrielatos G, Efremidis M, Kounas SP, Filippatos GS, Sideris A, Kardaras F. Prevalence of Brugada sign in a Greek tertiary hospital population. Europace. 2007;9:1077–80.

    Article  PubMed  Google Scholar 

  47. Gallagher MM, Forleo GB, Behr ER, Magliano G, De LL, Morgia V, De LF, Romeo F. Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects. Int J Cardiol. 2007;130:44–8.

    Article  PubMed  Google Scholar 

  48. Schukro C, Berger T, Stix G, Pezawas T, Kastner J, Hintringer F, Schmidinger H. Regional prevalence and clinical benefit of implantable cardioverter defibrillators in Brugada syndrome. Int J Cardiol. 2010;144:191–4.

    Article  PubMed  Google Scholar 

  49. Pecini R, Cedergreen P, Theilade S, Haunso S, Theilade J, Jensen GB. The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study. Europace. 2010;12:982–6.

    Article  PubMed  Google Scholar 

  50. Sinner MF, Pfeufer A, Perz S, Schulze-Bahr E, Monnig G, Eckardt L, Beckmann BM, Wichmann HE, Breithardt G, Steinbeck G, Fabritz L, Kaab S, Kirchhof P. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. Europace. 2009;11:1338–44.

    Article  PubMed  Google Scholar 

  51. Monroe MH, Littmann L. Two-year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital. Clin Cardiol. 2000;23:849–51.

    Article  CAS  PubMed  Google Scholar 

  52. Greer RW, Glancy DL. Prevalence of the Brugada electrocardiographic pattern at the Medical Center of Louisiana in New Orleans. J La State Med Soc. 2003;155:242–6.

    PubMed  Google Scholar 

  53. Ito H, Yano K, Chen R, He Q, Curb JD. The prevalence and prognosis of a Brugada-type electrocardiogram in a population of middle-aged Japanese-American men with follow-up of three decades. Am J Med Sci. 2006;331:25–9.

    Article  PubMed  Google Scholar 

  54. Donohue D, Tehrani F, Jamehdor R, Lam C, Movahed MR. The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States. Am Heart Hosp J. 2008;6:48–50.

    Article  PubMed  Google Scholar 

  55. Patel SS, Anees SS, Ferrick KJ. Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States. Pacing Clin Electrophysiol. 2009;32:704–8.

    Article  PubMed  Google Scholar 

  56. Viskin S, Fish R, Eldar M, Zeltser D, Lesh MD, Glick A, Belhassen B. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls. Heart. 2000;84:31–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M. Risk stratification in Brugada syndrome results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol. 2012;59:37–45.

    Article  PubMed  Google Scholar 

  58. Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud J-B, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié J-L, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M. Outcome after implantation of cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study – part 2. Circulation. 2013;128:1739–47.

    Article  PubMed  Google Scholar 

  59. Takagi M, Sekiguchi Y, Yokoyama Y, Aihara N, Hiraoka M, Aonuma K, Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan. Heart Rhythm. 2014;11:1716–20.

    Article  PubMed  Google Scholar 

  60. Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia G-B, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. J Am Coll Cardiol. 2015;65:879–88.

    Article  PubMed  Google Scholar 

  61. Bjerregaard P, Gussak I, Kotar SL, Gessler JE, Janosik D. Recurrent syncope in a patient with prominent J wave. Am Heart J. 1994;127:1426–30.

    Article  CAS  PubMed  Google Scholar 

  62. Bonny A, Tonet J, Fontaine G, Lacotte J, Coignard E, Duthoit G, Hidden-Lucet F, Charron P, Brugada P, Frank R. Brugada syndrome in pure black Africans. J Cardiovasc Electrophysiol. 2008;19:421–6.

    Article  PubMed  Google Scholar 

  63. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, Babuty D, Villain E, Victor J, Schott JJ, Lupoglazoff JM, Mabo P, Veltmann C, Jesel L, Chevalier P, Clur SA, Haissaguerre M, Wolpert C, Le Marec H, Wilde AA. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115:2042–8.

    Article  PubMed  Google Scholar 

  64. Chockalingam P, Clur S-AB, Breur JMPJ, Kriebel T, Paul T, Rammeloo LA, Wilde AAM, Blom NA. The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. Heart Rhythm. 2012;9:1986–92.

    Article  PubMed  Google Scholar 

  65. Brugada J, Brugada P, Brugada R. The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death – the Brugada syndrome. Europace. 1999;1:156–66.

    Article  CAS  PubMed  Google Scholar 

  66. Itoh H, Shimizu M, Ino H, Okeie K, Yamaguchi M, Fujino N, Mabuchi H. Arrhythmias in patients with Brugada-type electrocardiographic findings. Jpn Circ J. 2001;65:483–6.

    Article  CAS  PubMed  Google Scholar 

  67. Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H, Haraoka K, Kobayashi M, Morita ST, Nakamura K, Emori T, Matsubara H, Hina K, Kita T, Fukatani M, Ohe T. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol. 2002;40:1437–44.

    Article  PubMed  Google Scholar 

  68. Fujiki A, Usui M, Nagasawa H, Mizumaki K, Hayashi H, Inoue H. ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10:214–8.

    Article  CAS  PubMed  Google Scholar 

  69. Nakazato Y, Nakata Y, Yasuda M, Nakazato K, Sumiyoshi M, Ogura S, Yamaguchi H. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias. Jpn Heart J. 1997;38:379–85.

    Article  CAS  PubMed  Google Scholar 

  70. Postema PG, Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM, Priori SG, Tan HL, Hiraoka M, Brugada J, Wilde AA. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm. 2009;6:1335–41.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Viskin S, Rosso R, Marquez MF, Antzelevitch C. The acquired Brugada syndrome and the paradox of choice. Heart Rhythm. 2009;6:1342–4.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Postema PG, van Dessel PF, Kors JA, Linnenbank AC, van Herpen G, van Ritsema EHJ, van Geloven N, de Bakker JM, Wilde AA, Tan HL. Local depolarization abnormalities are the dominant pathophysiologic mechanism for the type-1 ECG in Brugada syndrome. A study of electrocardiograms, vectorcardiograms and body surface potential maps during ajmaline provocation. J Am CollCardiol. 2010;55:789–97.

    Article  PubMed  Google Scholar 

  73. Eckardt L, Kirchhof P, Loh P, Schulze-Bahr E, Johna R, Wichter T, Breithardt G, Haverkamp W, Borggrefe M. Brugada syndrome and supraventricular tachyarrhythmias: a novel association? J Cardiovasc Electrophysiol. 2001;12:680–5.

    Article  CAS  PubMed  Google Scholar 

  74. Schimpf R, Giustetto C, Eckardt L, Veltmann C, Wolpert C, Gaita F, Breithardt G, Borggrefe M. Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome. Ann Noninvasive Electrocardiol. 2008;13:266–9.

    Article  PubMed  Google Scholar 

  75. Postema PG, Tan HL, Wilde AA. Ageing and Brugada syndrome: considerations and recommendations. J Geriatr Cardiol. 2013;10:75–81.

    PubMed  PubMed Central  Google Scholar 

  76. Bouzeman A, Traulle S, Messali A, Extramiana F, Denjoy I, Narayanan K, Marijon E, Hermida J-S, Leenhardt A. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine. Europace. 2014;16:572–7.

    Article  PubMed  Google Scholar 

  77. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol. 2009;32:294–301.

    Article  PubMed  Google Scholar 

  78. Giustetto C, Cerrato N, Gribaudo E, Scrocco C, Castagno D, Richiardi E, Giachino D, Bianchi F, Barbonaglia L, Ferraro A. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis. Heart Rhythm. 2014;11:259–65.

    Article  PubMed  Google Scholar 

  79. Viskin S, Wilde AA M, Guevara-Valdivia ME, Daoulah A, Krahn A, Zipes DP, Halkin A, Shivkumar K, Boyle NG, Adler A, Belhassen B, Schapachnik E, Asrar F, Rosso R. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol. 2013;61:2383–7.

    Article  PubMed  Google Scholar 

  80. Wilde AA, Langendijk PN. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders? Neth Heart J. 2007;15:127–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Tada H, Nogami A, Shimizu W, Naito S, Nakatsugawa M, Oshima S, Taniguchi K. ST segment and T wave alternans in a patient with Brugada syndrome. Pacing Clin Electrophysiol. 2000;23:413–5.

    Article  CAS  PubMed  Google Scholar 

  82. Sarkozy A, Caenepeel A, Geelen P, Peytchev P, de Zutter M, Brugada P. Cibenzoline induced Brugada ECG pattern. Europace. 2005;7:537–9.

    Article  PubMed  Google Scholar 

  83. Chinushi M, Aizawa Y, Ogawa Y, Shiba M, Takahashi K. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol. 1997;30:133–6.

    Article  CAS  PubMed  Google Scholar 

  84. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, Sunagawa K, Kamakura S. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000;11:1320–9.

    Article  CAS  PubMed  Google Scholar 

  85. Sugao M, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Iwamoto J, Mizumaki K, Inoue H. Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol. 2005;45:545–9.

    Article  CAS  PubMed  Google Scholar 

  86. Sumi S, Maruyama S, Shiga Y, Kodama S, Miyoshi K, Tojou H, Yamanouchi Y, Urata H. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome. Pacing Clin Electrophysiol. 2010;33:e53–6.

    Article  PubMed  Google Scholar 

  87. Krishnan SC, Josephson ME. ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol. 1998;9:1167–72.

    Article  CAS  PubMed  Google Scholar 

  88. Matana A, Goldner V, Stanic K, Mavric Z, Zaputovic L, Matana Z. Unmasking effect of propafenone on the concealed form of the Brugada phenomenon. Pacing Clin Electrophysiol. 2000;23:416–8.

    Article  CAS  PubMed  Google Scholar 

  89. Akdemir I, Davutoglu V, Aksoy M. Intermittent Brugada syndrome misdiagnosed as acute myocardial infarction and unmasked with propafenone. Heart. 2002;87:543.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Hasdemir C, Olukman M, Ulucan C, Roden DM. Brugada-type ECG pattern and extreme QRS complex widening with propafenone overdose. J Cardiovasc Electrophysiol. 2006;17:565–6.

    Article  PubMed  Google Scholar 

  91. Shan Q, Yang B, Chen M, Zou J, Chen C, Xu D, Cao K. Short-term normalization of ventricular repolarization by transcatheter ablation in a patient with suspected Brugada Syndrome. J Interv Card Electrophysiol. 2008;21:53–7.

    Article  PubMed  Google Scholar 

  92. Shimada M, Miyazaki T, Miyoshi S, Soejima K, Hori S, Mitamura H, Ogawa S. Sustained monomorphic ventricular tachycardia in a patient with Brugada syndrome. Jpn Circ J. 1996;60:364–70.

    Article  CAS  PubMed  Google Scholar 

  93. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95:2277–85.

    Article  CAS  PubMed  Google Scholar 

  94. Aouate P, Clerc J, Viard P, Seoud J. Propranolol intoxication revealing a Brugada syndrome. J Cardiovasc Electrophysiol. 2005;16:348–51.

    Article  PubMed  Google Scholar 

  95. Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, Sitthisook S, Chaothawee L, Lai MY, Azen SP. Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation. 2003;107:2221–6.

    Article  PubMed  Google Scholar 

  96. Chockalingam P, Rammeloo LA, Postema PG, Hruda J, Clur SA, Blom NA, Wilde AA. Fever-induced life-threatening arrhythmias in children harboring an SCN5A mutation. Pediatrics. 2011;127:e239–44.

    Article  PubMed  Google Scholar 

  97. Postema PG, Woosley RL. Use of drugs in Long QT syndrome type 3 and Brugada syndrome. Card Electrophysiol Clin. 2014;6:811–7.

    Article  Google Scholar 

  98. Paul G, Yusuf S, Sharma S. Unmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusion. Circulation. 2006;114:e489–91.

    Article  PubMed  Google Scholar 

  99. D’Aloia A, Vizzardi E, Bugatti S, Zanini G, Bontempi L, Curnis A. Brugada syndrome phenotype cardiac arrest in a young patient unmasked during the acute phase of amiodarone infusion: disclosure and aggravation of Brugada electrocardiographic pattern. J Electrocardiol. 2012;45:411–3.

    Article  PubMed  Google Scholar 

  100. Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P. Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome. Pacing Clin Electrophysiol. 2000;23:410–2.

    Article  CAS  PubMed  Google Scholar 

  101. Zografos TA, Kourouklis SP, Katsivas A. Type 1 Brugada pattern exacerbation and 1:1 atrioventricular conduction induced by vernakalant. Heart Rhythm. 2014;11:895–7.

    Article  PubMed  Google Scholar 

  102. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S, Ohe T, Shimizu W. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm. 2007;4:695–700.

    Article  PubMed  Google Scholar 

  103. Murakami M, Nakamura K, Kusano KF, Morita H, Nakagawa K, Tanaka M, Tada T, Toh N, Nishii N, Nagase S, Hata Y, Kohno K, Miura D, Ohe T, Ito H. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in Brugada syndrome patients with and without SCN5A mutation. J Cardiovasc Pharmacol. 2010;56:389–95.

    Article  CAS  PubMed  Google Scholar 

  104. Chinushi M, Furushima H, Hosaka Y, Izumi D, Aizawa Y. Ventricular fibrillation and ventricular tachycardia triggered by late-coupled ventricular extrasystoles in a Brugada syndrome patient. Pacing Clin Electrophysiol. 2011;34:e1–5.

    Article  PubMed  Google Scholar 

  105. Kaneko Y, Horie M, Niwano S, Kusano KF, Takatsuki S, Kurita T, Mitsuhashi T, Nakajima T, Irie T, Hasegawa K, Noda T, Kamakura S, Aizawa Y, Yasuoka R, Torigoe K, Suzuki H, Ohe T, Shimizu A, Fukuda K, Kurabayashi M, Aizawa Y. Electrical storm in patients with Brugada syndrome is associated with early repolarization. Circ Arrhythm Electrophysiol. 2014;7:1122–8.

    Article  PubMed  Google Scholar 

  106. Conte G, Chierchia G-B, Wauters K, De Asmundis C, Sarkozy A, Levinstein M, Sieira J, Baltogiannis G, Di Giovanni G, Ciconte G, Casado-Arroyo R, Saitoh Y, Brugada P. Pulmonary vein isolation in patients with Brugada syndrome and atrial fibrillation: a 2-year follow-up. Europace. 2014;16:528–32.

    Article  PubMed  Google Scholar 

  107. Tomita T, Aizawa K, Shimada K, Motoki H, Otagiri K, Koshikawa M, Kasai H, Izawa A, Kumazaki S, Tsutsui H, Koyama J, Ikeda U. Influence of circumferential pulmonary vein isolation for atrial fibrillation on ST elevation in patient with Brugada syndrome. Int J Cardiol. 2011;149:e82–4.

    Article  PubMed  Google Scholar 

  108. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O’neill MD, Garrigue S, Pierre B, Jais P, Pasquie JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clementy J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome. A multicenter study. Circulation. 2006;114:2317–24.

    Article  PubMed  Google Scholar 

  109. Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28:334–44.

    Article  PubMed  Google Scholar 

  110. Olde Nordkamp LRA, Wilde AAM, Tijssen JGP, Knops RE, van Dessel PFHM, de Groot JR. The ICD for primary prevention in patients with inherited cardiac diseases: indications, utilization and outcome. A comparison with secondary prevention. Circ Arrhythm Electrophysiol. 2013;6:91–100.

    Article  PubMed  Google Scholar 

  111. Remme CA, Wilde AA, Bezzina CR. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med. 2008;18:78–87.

    Article  CAS  PubMed  Google Scholar 

  112. Smits JP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA, Haverkamp W, Breithardt G, Escande D, Schulze-Bahr E, Le Marec H, Wilde AA. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol. 2002;40:350–6.

    Article  CAS  PubMed  Google Scholar 

  113. Postema PG, van den Berg MP, van Tintelen JP, van den Heuvel F, Grundeken M, Hofman N, van der Roest WP, Nannenberg EA, Krapels IP, Bezzina CR, Wilde AA. Founder mutations in the Netherlands. SCN5a 1795insD, the first described arrhythmia overlap syndrome and one of the largest and best described characterised families worldwide. Neth Heart J. 2009;17:422–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Rossenbacker T, Carroll SJ, Liu H, Kuiperi C, de Ravel TJ, Devriendt K, Carmeliet P, Kass RS, Heidbuchel H. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm. 2004;1:610–5.

    Article  PubMed  Google Scholar 

  115. Makita N, Behr E, Shimizu W, Horie M, Sunami A, Crotti L, Schulze-Bahr E, Fukuhara S, Mochizuki N, Makiyama T, Itoh H, Christiansen M, McKeown P, Miyamoto K, Kamakura S, Tsutsui H, Schwartz PJ, George AL, Roden DM. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. J Clin Invest. 2008;118:2219–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  116. Van den Berg MP, Wilde AA, Viersma JW, Brouwer J, Haaksma J, van der Hout AH, Stolte-Dijkstra I, Bezzina TCR, van Langen I, Beaufort-Krol GC, Cornel JH, Crijns HJ. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol. 2001;12:630–6.

    Article  PubMed  Google Scholar 

  117. Van den Berg MP, Haaksma J, Veeger NJ, Wilde AA. Diurnal variation of ventricular repolarization in a large family with LQT3-Brugada syndrome characterized by nocturnal sudden death. Heart Rhythm. 2006;3:290–5.

    Article  PubMed  Google Scholar 

  118. Boersma LV, Jaarsma W, Jessurun ER, Van Hemel NH, Wever EF. Brugada syndrome: a case report of monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 2001;24:112–5.

    Article  CAS  PubMed  Google Scholar 

  119. Allocca G, Proclemer A, Nucifora G, Dall’Armellina E, Rebellato L. Monomorphic ventricular tachycardia in “Brugada syndrome”: clinical case and literature review. J Cardiovasc Med (Hagerstown). 2008;9:842–6.

    Article  Google Scholar 

  120. Huang MH, Marcus FI. Idiopathic Brugada-type electrocardiographic pattern in an octogenarian. J Electrocardiol. 2004;37:109–11.

    Article  PubMed  Google Scholar 

  121. Nannenberg EA, Sijbrands EJG, Dijksman LM, Alders M, van Tintelen JP, Birnie M, van Langen IM, Wilde AAM. Mortality of inherited arrhythmia syndromes: insight into their natural history. Circ Cardiovasc Genet. 2012;5:183–9.

    Article  PubMed  Google Scholar 

  122. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, Taguchi A, Suyama K, Kamakura S, Shimomura K. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999;20:465–70.

    Article  CAS  PubMed  Google Scholar 

  123. Nishizaki M, Sakurada H, Mizusawa Y, Niki S, Hayashi T, Tanaka Y, Maeda S, Fujii H, Ashikaga T, Yamawake N, Isobe M, Hiraoka M. Influence of meals on variations of ST segment elevation in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2008;19:62–8.

    PubMed  Google Scholar 

  124. Mizumaki K, Fujiki A, Nishida K, Iwamoto J, Sakamoto T, Sakabe M, Tsuneda T, Sugao M, Inoue H. Postprandial augmentation of bradycardia-dependent ST elevation in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18:839–44.

    Article  PubMed  Google Scholar 

  125. Morita H, Fukushima-Kusano K, Nagase S, Takenaka-Morita S, Nishii N, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T. Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2003;14:373–9.

    Article  PubMed  Google Scholar 

  126. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation. 2011;123:1270–9.

    Article  PubMed  Google Scholar 

  127. Cortez-Dias N, Plácido R, Marta L, Bernardes A, Sobral S, Carpinteiro L, de Sousa J. Epicardial ablation for prevention of ventricular fibrillation in a patient with Brugada Syndrome. Rev Port Cardiol. 2014;33(305):e1–e7.

    Google Scholar 

  128. Sacher F, Jesel L, Jais P, Haïssaguerre M. Insight into the mechanism of Brugada syndrome, epicardial substrate and modification during ajmaline testing. Heart Rhythm. 2013;11:732–4.

    Article  PubMed  Google Scholar 

  129. Széplaki G, Ozcan EE, Osztheimer I, Tahin T, Merkely B, Gellér L. Ablation of the epicardial substrate in the right ventricular outflow tract in a patient with Brugada syndrome refusing implantable cardioverter defibrillator therapy. Can J Cardiol. 2014;30:1249.e9–11.

    Article  Google Scholar 

  130. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73–8.

    Google Scholar 

  131. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL le Marec H, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissauerre M, Mabo P, Wolpert C, Wilde AAM. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 2010;121:635–3.

    Google Scholar 

  132. Sacher F, Arsac F, Wilton SB, Derval N, Denis A, de Guillebon M, Ramoul K, Bordachar P, Ritter P, Hocini M, Clémenty J, Jaïs P, Haïssaguerre M. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm. 2012;9:1272–9.

    Article  PubMed  Google Scholar 

  133. Take Y, Morita H, Toh N, Nishii N, Nagase S, Nakamura K, Kusano KF, Ohe T, Ito H. Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm. 2012;9:752–9.

    Article  PubMed  Google Scholar 

  134. Olde Nordkamp LRA, Vink AS, Wilde AAM, de Lange FJ, de Jong JSSG, Wieling W, van Dijk N, Tan HL. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from non-arrhythmic causes. Heart Rhythm. 2015;12:367–75.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heart Centre, Department of Clinical and Experimental Cardiology, Academic Medical Centre, University of Amsterdam, Meibergdreef 15, Amsterdam, 1105 AZ, The Netherlands

    Arthur A. M. Wilde MD, PhD & Pieter G. Postema MD, PhD

  2. Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders, Jeddah, Saudi Arabia

    Arthur A. M. Wilde MD, PhD

Authors
  1. Arthur A. M. Wilde MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pieter G. Postema MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur A. M. Wilde MD, PhD .

Editor information

Editors and Affiliations

  1. Cardiovascular Research, Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA

    Charles Antzelevitch

  2. Lankenau Institute for Medical Research, Lankenau Medical Center, Wynnewood, Pennsylvania, USA

    Gan-Xin Yan

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wilde, A.A.M., Postema, P.G. (2016). Prevalence and Clinical Characteristics of Brugada Syndrome. In: Antzelevitch, C., Yan, GX. (eds) J Wave Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-31578-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31578-2_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31576-8

  • Online ISBN: 978-3-319-31578-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation